CompoAtlas

AL-R STOP

Food supplement declared in France, decision dated 6 November 2026

AL-R STOP is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
SANTISLAB FRANCE SAS
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 à 3 comprimés
Directions for use
1 à 3 comprimés par jour, à avaler avec un peu d'eau.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney failure, Infants (under 1 year), Heart problems, Prolonged use, Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Immunity

Declaration 378216, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Plantago major L.FeuilleExtrait sec aqueux270 mg
Ribes nigrum L.BourgeonExtrait sec aqueux150 mg

Substances

NamePer day
méthylsulfonate de méthane1,050 mg
quercétine15 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Gluconate de cuivreCuivre5,000 µg2,000 µg
Gluconate de manganèseManganèse8 mg (safe level)3.5 mg
Citrate de zincZinc25 mg15 mg

Additives

E464, E470b, E341, E460

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé aux adultes. Déconseillé aux femmes enceintes et allaitantes. Déconseillé en cas d'insuffisance cardiaque ou rénale œdémateuse. Usage prolongé déconseillé.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • méthylsulfonate de méthane
    Read the warning, when it applies and the studies cited

    MSM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • quercétine
    Read the warning, when it applies and the studies cited

    QUERCETIN

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 40 milligrams or more Quercetin, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line